Twitter Inc (TWTR) the Best among Social Stocks: FMHR Traders

When Twitter Inc (NYSE:TWTR) came up with its unexpected results recently, not only did it set its stock soaring, but also the way Wall Street perceives it changed drastically. Before the results the company was facing intense pressure from Wall Street, owing to the spectacular results by the competitor that it is routinely compared to, Facebook Inc (NASDAQ:FB). Now that the results are out it seems it has become the favorite social stock of the Street.

500px-Twitter_Logo_Blue.svg

CNBC’s Fast Money Halftime Traders’ Pete Najarian, Tim Seymour and Brian Kelly discussed Twitter Inc (NYSE:TWTR) results and compared it with other social stocks like Yelp Inc (NYSE:YELP) and Facebook Inc (NASDAQ:FB).

“Twitter Inc (NYSE:TWTR) and Facebook Inc (NASDAQ:FB) have defined things that you are going to use and very little competition, where Yelp Inc (NYSE:YELP) has an awful lot of competition. You have Google Inc (NASDAQ:GOOGL) coming into the space, you have OpenTable coming into the space in some ways. So, there are other alternatives here,” Kelly said.

According to Najarian Facebook Inc (NASDAQ:FB) and Twitter Inc (NYSE:TWTR) are different companies even though both are in the social media space. He feels that what matters for social stocks is if they have growth, and Facebook Inc (NASDAQ:FB) and Twitter Inc (NYSE:TWTR) have proved that they have it with their quarterly earnings, increase in user base and advertising revenues. Mr. Najarian also feels that the stocks of Facebook Inc (NASDAQ:FB) and Twitter Inc (NYSE:TWTR) can hold the levels where they are trading right now because the excitement is back in these stocks.

“The other thing is do you have scale? When you get into this space, not everyone is going to win. I think two or three quarters back people were just betting on anyone in social media. You are getting at a place where Yelp Inc (NYSE:YELP) really needs to prove […],” Seymour added.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!